Skip to main content

People in the News: New Appointments at Genomind, Veracyte, Rebus Biosystems, More

Genomind: Cynthia Kilroy

Genomind, a company developing pharmacogenetic tests for mental health conditions, has appointed Cythia Kilroy as chief strategy and corporate development officer. She joins the company from Cognizant, where she held positions in the healthcare and health strategy groups. Kilroy has also previously worked for Optum, Huron Consulting Group, and her own firm, CCK Consulting.

Genomind has also appointed Stephen Saklad to its scientific advisory board. Saklad is a clinical professor of pharmacotherapy, and adjoint professor at the University of Texas School of Medicine; and director of the Psychiatric Pharmacy Program at the San Antonio State Hospital, Texas Department of State Health Services. He is an expert clinical pharmacologist with special interest in psychopharmacology, and holds a doctor of pharmacy degree from the University of Southern California.


Veracyte: Muna Bhanji 

Veracyte has appointed Muna Bhanji to its board of directors. Bhanji most recently served as senior VP of global market access and policy, global human health at Merck. She has previously served on the board of Possible Health and the Foundation of Managed Care Pharmacy. Bhanji currently serves on the boards of Ardelyx, Cytokinetics, and Corus International.


Rebus Biosystems: Neil Kennedy, Scott Kothlow 

Spatial omics technology firm Rebus Biosystems announced the appointments of Neil Kennedy as chief commercial officer and Scott Kothlow as chief financial officer.

Kennedy will lead commercialization of Rebus' Esper platform, including sales, marketing, product management, and customer success. Kennedy brings 25 years of commercial experience, most recently as senior VP of commercial operations at Dovetail Genomics.

Kothlow brings 30 years of financial experience in the life sciences industry. He was previously CFO at Somalogic.


For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.